Bradykinin receptors and their antagonists

European Journal of Pharmacology

Volumn 348, Issue 1, 1998, Pages 1-10

  Regoli, Domenico ^a   Nsa Allogho, Suzanne ^a   Rizzi, Anna ^a   Gobeil, Fernand Junior ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Bradykinin; Bradykinin B1 receptor; Bradykinin B2 receptor; Bradykinin receptor antagonist; DesArg9 bradykinin; Kinin

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; ACRYLAMIDE DERIVATIVE; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ RECEPTOR; BRADYKININ[1-8]; BRADYKININ[5,8 [3 (2 THIENYL)ALANINE] 7 DEXTRO PHENYLALANINE]; BRADYKININ[8 LEUCINE 9 DEARGININE]; ICATIBANT; KALLIDIN; PARTIAL AGONIST; UNCLASSIFIED DRUG; [[4 [2 [[BIS(CYCLOHEXYLAMINO)METHYLENE]AMINO] 3 (2 NAPHTHYL)PROPIONAMIDO]PHENYL]METHYL]TRIBUTYLPHOSPHONIUM CHLORIDE;

AMINO TERMINAL SEQUENCE; BINDING AFFINITY; BINDING SITE; DRUG DEGRADATION; DRUG POTENCY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR BLOCKING; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0032077036     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00165-4     Document Type: Article

References (87)

1. Akbary A.M., Wirth K.J., Schölkens B.A. Efficacy and tolerability of Icatibant (HOE 140) in patients with moderately severe chronic bronchial asthma. Immunopharmacology. 33:1996;238-242.
2. 2 receptor antagonist, FR 173657. Br. J. Pharmacol. 120:1997;617-624.
3. 2 kinin receptor antagonist, of antigen-induced nasal blockage. Br. J. Pharmacol. 111:1994;969-971.
4. Aramori I., Zenkoh J., Morikawa N., O'Donnel N., Asano M., Nakamura K., Iwami M., Kojo H., Notsu Y. Novel subtype-selective nonpeptide bradykinin receptor antagonists FR 167344 and FR 173657. Mol. Pharmacol. 51:1997;171-176.
5. 1 receptor in Chinese hamster ovary cells. J. Biol. Chem. 272:1997;11420-11425.
6. Barnes P.J. Bradykinin and asthma. Thorax. 47:1992;979-983.
7. Bascands J.L., Girolami J.P. La bradykinine. Méd./Sci. 12:1996;582-592.
8. Bascands J.L., Pecher C., Rouaud S., Emond C., Leung Tack J., Bastie M.J., Burch R., Regoli D., Girolami J.P. Evidence for existence of two distinct bradykinin receptors on rats mesangial cells. Am. J. Physiol. 264:1993;F548-F556.
9. Bastian S., Loillier B., Paquet J.L., Pruneau D. Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization. Br. J. Pharmacol. 122:1997;393-399.
10. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev. 44:1992;1-80.
11. Clemens J.A. The human kallikrein gene family: a diversity of expression and function. Mol. Cell. Endocrinol. 99:1994;C1-C6.
12. Clemens, J.A., 1997. The molecular biology of the kallikreins and their roles in inflammation. In: Farmer, S.G. (Ed.), The Kinin System. Academic Press, San Diego, pp. 71-97.
13. 9 bradykinin in vivo and in vitro. Immunopharmacology. 17:1989;187-198.
14. Dray A., Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 16:1993;99-104.
15. Drouin J.N., Gaudreau P., St-Pierre S.A., Regoli D. Biological activities of kinins modified at the N- or the C-terminal end. Can. J. Physiol. Pharmacol. 57:1979;1018-1023.
16. 2 receptor gene. Biochem. Biophys. Res. Commun. 187:1992;1306-1313.
17. Farmer, S.G., 1997. The kallikrein-kinin system in asthma and acute respiratory distress syndrome. In: Farmer, S.G. (Ed.), The Kinin System. Academic Press, San Diego, pp. 249-263.
18. 3 receptor. Br. J. Pharmacol. 112:1994;461-464.
19. 3 receptor. Mol. Pharmacol. 36:1989;1-8.
20. Félétou M., Martin C.A.E., Molimard M., Naline E., Germain M., Thurieau C., Fauchère J.L., Canet E., Advenier C. In vitro effects of HOE 140 in human bronchial and vascular tissue. Eur. J. Pharmacol. 274:1995;57-64.
21. Ferguson S.S.G., Barak L.S., Zhang J., Caron M.G. G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can. J. Physiol. Pharmacol. 74:1996;1095-1110.
22. Gaudreau P., Barabé J., St-Pierre S., Regoli D. Pharmacological studies of kinins on venous smooth muscles. Can. J. Physiol. Pharmacol. 59:1981;371-379.
23. 2 type characterized by binding. Br. J. Pharmacol. 122:1997;1450-1454.
24. Geppetti P. Sensory neuropeptide release by bradykinin: mechanisms and pathological implications. Regul. Pep. 47:1993;1-23.
25. Gobeil F., Regoli D. Characterization of kinin receptors by bioassays. Braz. J. Med. Biol. Res. 27:1994;1781-1791.
26. Gobeil F., Pheng L.H., Badini I., Nguyen-Le X.K., Pizard A., Rizzi A., Blouin D., Regoli D. Receptors for kinins in the human isolated umbilical vein. Br. J. Pharmacol. 118:1996;289-294.
27. 1 receptor-related peptides. Antagonists. Hypertension. 28:1996;833-839.
28. 1 receptor antagonist, the R-715. Abstract, 5th International Symposium on Resistance Arteries, Cambridge, UK. J. Vascul. Res., 33 (suppl. 2) 30.
29. 2 receptors in the rabbit and the guinea pig. Can. J. Physiol. Pharmacol. 74:1996;137-144.
30. 1 receptors. Can. J. Physiol. Pharmacol. 75:1997;591-595.
31. Griesbacher T., Lembeck F. Effects of the bradykinin antagonist HOE 140, in experimental acute pancreatitis. Br. J. Pharmacol. 107:1992;356-360.
32. Hall J.M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 56:1992;131-190.
33. Hall, J.M., Morton, I, K.M., 1997. The pharmacology and immuno-pharmacology of kinin receptors. In: Farmer, S.G. (Ed.), The Kinin System. Academic Press, San Diego, pp. 9-43.
34. 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J. Biol. Chem. 264:1989;12657-12665.
35. Hess J.F., Borkowski J.A., Young G.S., Strader C.D., Ransom R.W. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 184:1992;260-268.
36. 2 bradykinin receptors. Mol. Pharmacol. 45:1994;1-8.
37. Hock F.J., Wirth K., Albus U., Linz W., Gerhards H.J., Wiemer G., Henke S., Breipohl G., König W., Knolle J., Schölkens B.A. HOE 140 a new potent and long acting bradykinin antagonist: in vitro studies. Br. J. Pharmacol. 102:1991;769-773.
38. 2 antagonist: in vitro and in vivo studies. Can. J. Physiol. Pharmacol. 75:1997;622-628.
39. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN), 1983. Nomenclature and symbolism for amino acids and peptides. Eur. J. Biochem. 138, pp. 9-37.
40. Kato H., Matsumuara Y., Maeda H. Isolation and identification of hydroxyproline analogues of bradykinin in human urine. FEBS Lett. 232:1988;252-254.
41. Lembeck F., Grierbacher T., Eckhardt M., Henke S., Breipohl G., Knolle J. New, long acting, potent bradykinin antagonists. Br. J. Pharmacol. 102:1991;297-304.
42. 1 receptors for kinins. Immunopharmacology. 29:1995;141-147.
43. Linz W., Wiemer G., Gohlke P., Unger T., Schölkens B.A. Contribution of kinins to the cardiovascular actions of angiotensin converting enzyme inhibitors. Pharmacol. Rev. 47:1995;25-49.
44. Lohse M.J. Molecular mechanisms of membrane receptor desensitization. Biochim. Biophys. Acta. 1179:1993;171-188.
45. Lopes P., Couture R. Cardiovascular responses elicited by intrathecal kinins in the conscious rat. Eur. J. Pharmacol. 210:1992;137-147.
46. Maggi, C.A., 1997. Bradykinin as an inflammatory mediator in the urinary tract. In: Farmer, S.G. (Ed.), The Kinin System. Academic Press, San Diego, pp. 235-247.
47. Maier M., Ressert G., Jerabek I., Lottspeich F., Binder B.R. Identification of (hydroxyproline)-lysyl-bradykinin released from kininogens by human urinary kallikreins. FEBS Lett. 232:1988;395-398.
48. 1 receptors: a review. Immunopharmacology. 30:1995;1-26.
49. 2 receptors on the venoconstrictor action of bradykinin. J. Pharmacol. Exp. Ther. 269:1994;1136-1143.
50. 1 bradykinin receptor. J. Biol. Chem. 269:1994;21583-21586.
51. Mombouli J.V., Vanhoutte P.M. Kinins and endothelial control of vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol. 35:1995;679-705.
52. 2 receptors in the mouse. Can. J. Physiol. Pharmacol. 73:1995;1759-1764.
53. 2 receptors in the mouse. Can. J. Physiol. Pharmacol. 75:1997;558-562.
54. 2 receptor mice. Naunyn-Schmiedeberg's Arch. Pharmacol., in press.
55. Polosa R. Role of the kallikrein pathway in allergic diseases. Allergy. 48:1993;217-225.
56. Proud D., Reynolds C.J., Lacapra S., Kagey-Sobotka A., Lichtenstein L.M., Nacleiro R.M. Nasal provocation with bradykinin induces symptoms of rhinitis and sore throat. Am. Rev. Respir. Dir. 137:1988;613-616.
57. 2 receptor. Br. J. Pharmacol. 114:1995;115-118.
58. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
59. Regoli D., Park W.K., Rioux F. Pharmacology of angiotensin. Pharmacol. Rev. 26:1974;69-123.
60. Regoli D., Barabé J., Park W.K. Receptors fo bradykinin in rabbit aortae. Can. J. Pharmacol. 55:1977;855-867.
61. 1 receptors for kinins in the rabbit by a bacterial lipopolysaccharide. Eur. J. Pharmacol. 71:1981;105-115.
62. Regoli D., Rhaleb N.E., Drapeau G., Dion S. Kinin receptor subtypes. J. Cardiovasc. Pharmacol. 15:1990;530-538. Suppl. 6.
63. 2 receptor characterization. Trends Pharmacol. Sci. 11:1990;156-161.
64. Regoli D., Jukic D., Gobeil F., Rhaleb N.E. Receptors for bradykinin and related kinins: a critical analysis. Can. J. Physiol. Pharmacol. 71:1993;556-567.
65. 2 subtypes. Life Sci. 55:1994;735-749.
66. Regoli D., Boudon A., Fauchère J.L. Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 46:1994;551-599.
67. Regoli, D., Geppetti, P., Hess, F., Marceau, F., Müller-Estrel, W., Schölkens, B.A., 1998. Classification of kinin receptors. IUPHAR Receptor Compendium, Pharmacol. Rev. (in press).
68. 2 receptor antagonists. Hypertension. 17:1991;107-115.
69. 8]BK. Eur. J. Pharmacol. 163:1992;263-272.
70. Rifo J., Pourat M., Vavrek R.J., Stewart J.M., Huidobrotoro J.P. Bradykinin receptor antagonists used to characterize the heterogeneity of bradykinin-induced responses in rat vas deferens. Eur. J. Pharmacol. 142:1987;305-312.
71. 2 receptor antagonist: an in vitro study. Hypertension. 29:1997;951-956.
72. Rodell T.C. The kallikrein/kinin system and kinin antagonists in trauma. Immunopharmacology. 33:1996;279-283.
73. 2 receptor. J. Med. Chem. 36:1993;2583-2584.
74. 2 receptor antagonist. Proc. Natl. Acad. Sci. USA. 91:1994;4693-4697.
75. Schild, H.O., 1973. Receptor classification with special reference to beta adrenergic receptors. In: Rang, H.P. (Ed.), Drug Receptors. University Park Press, Baltimore, pp. 1129-1136.
76. 2 receptor antagonist, on guinea-pig trachea. Br. J. Pharmacol. 115:1995;1127-1128.
77. 2 kinin receptors in cultured porcine aortic endothelial cells. J. Pharmacol. Exp. Ther. 252:1990;581-585.
78. Schmaier, A.H., 1997. Gene expression, regulation and cell surface presentation of the kininogens. In: Farmer, S.G. (Ed.), The Kinin System. Academic Press, San Diego, pp. 57-70.
79. 2 bradykinin receptors in bovine pulmonary artery endothelial cells. Mol. Pharmacol. 47:1995;525-534.
80. Steranka L.R., Manning D.C., Dehaas C.J., Ferkany J.W., Borosky S.A., Connor J.R., Vavrek R.J., Stewart J.M., Snyder S.H. Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic action. Proc. Natl. Acad. Sci. 85:1988;3245-3249.
81. 2 bradykinin antagonists. In: Burch, R.M. (Ed.), Bradykinin Antagonists. Basic and Clinical Research. Marcel Dekker, New York, pp. 51-69.
82. Stewart J.M., Gera L., Hanson W., Zuzack J.S., Burkard M., McCullough R., Whalley E.T. Immunopharmacology. 33:1996;51-60.
83. Toda M., Bian K., Akiba T., Okamura T. Heterogeneity in mechanisms of bradykinin action in canine isolated blood vessels. Eur. J. Pharmacol. 135:1987;321-329.
84. Tousignant C., Dion S., Drapeau G., Regoli D. Characterization of pre- and post-junctional receptors for kinins and neurokinins in the rat vas deferens. Neuropeptides. 9:1987;333-343.
85. Vavrek R., Stewart J.M. Competitive antagonists of bradykinin. Peptides. 6:1985;161-164.
86. Wirth K., Hock F.J., Albus U., Linz W., Alpermann H.G., Anagnostopoulos H., Henke S., Breipohl G., König W., Knolle J., Schölkens B.A. HOE 140 a new potent and long acting bradykinin antagonist: in vivo studies. Br. J. Pharmacol. 102:1991;774-777.
87. 1 receptor. J. Pharmacol. Exp. Ther. 277:1996;1337-1343.